PennantPark Floating Rate Capital Ltd. — Form 10-Q
Reporting-period note: The filing covers the quarter ended March 31, 2024 and the six months ended March 31, 2024. This is the company’s fiscal second quarter of 2024, not 2023 Q2 as the request metadata suggests. Figures below are in U.S. dollars; financial statement amounts are in millions unless stated otherwise.
Business context and period
PennantPark is an externally managed business development company (BDC) investing primarily in floating-rate loans to middle-market companies. Its stated objectives are current income and capital appreciation while seeking to preserve capital. At March 31, 2024, the portfolio included 146 companies, was approximately 100% variable-rate in its debt investments, and had a 12.3% weighted-average yield on debt investments.
Key financial metrics
| Metric | Three months ended March 31, 2024 | Six months ended March 31, 2024 | Comparable 2023 period |
|---|---|---|---|
| Investment income | $44.4 | $82.3 | $34.6 / $65.9 |
| Net investment income | $19.1; $0.31 per share | $38.5; $0.64 per share | $16.7 / $30.5; $0.35 / $0.65 per share |
| Net realized investment gains (losses) | $4.0 | $0.9 | $(7.8) / $(7.8) |
| Net realized and unrealized gains from investments and debt | $12.0 | $15.0 | $(9.5) / $(24.9) |
| Increase in net assets from operations | $31.1; $0.51 per share | $53.6; $0.89 per share | $7.2 / $5.6; $0.15 / $0.12 per share |
| Net assets / NAV per share | $720.7 / $11.40 at March 31, 2024 | $653.6 / $11.13 at September 30, 2023 | |
| Cash and cash equivalents | $125.3 at March 31, 2024 | $100.6 at September 30, 2023 | |
| Operating cash flow | $(354.6) for six months | $15.3 for six months | |
| Total debt, carrying value | Approximately $861.5 at March 31, 2024 | Approximately $495.4 at September 30, 2023 |
The company declared distributions of $0.3075 per share for the quarter and $0.615 per share for the six-month period. Six-month total expenses were $43.8 million, including $23.6 million of debt interest and expenses. Total expense-to-average-net-assets ratio was 12.97% and net-investment-income ratio was 11.42%, both annualized as presented in the filing. The six-month weighted-average cost of debt was 7.1%, up from 5.8% a year earlier.
Material changes versus the prior comparable period
- Investment income increased 28% for the quarter and 25% for the six-month period, primarily reflecting a larger debt portfolio and higher cost yield.
- Net investment income rose in total dollars, but fell per share year over year: $0.31 versus $0.35 for the quarter and $0.64 versus $0.65 for six months.
- Operating results improved substantially, including a shift from prior-period realized losses and unrealized depreciation to gains in 2024.
- Portfolio fair value grew to $1.478 billion from $1.067 billion at September 30, 2023. The company reported net unrealized depreciation of $11.8 million, improved from $25.7 million at fiscal year-end.
- The portfolio had one company on non-accrual, versus three at September 30, 2023. Non-accrual investments represented 0.4% of portfolio cost and 0.3% of fair value.
- Leverage increased: asset coverage was 183%, down from 230% at September 30, 2023, against a 150% statutory minimum. Debt growth included a new $287 million 2036 asset-backed debt issuance; the company also repaid its remaining 2023 Notes.
Outlook, risks, contingencies and unusual items
- Outlook: The filing provides no specific earnings or distribution guidance. Management said liquidity and capital resources were sufficient to pursue market opportunities, while cautioning that future operating results and distributions are uncertain.
- Liquidity and financing: The $386 million revolving Credit Facility had $168.9 million drawn and $217.1 million of unused capacity at quarter-end, subject to leverage and borrowing-base limits. Its revolving period ends in August 2024 and it matures in August 2026. On April 9, 2024, commitments increased by $50 million to $436 million.
- Commitments: The company reported $300.2 million of commitments to fund investments, plus $39.4 million of unfunded commitments to PSSL. The filing says the company was compliant with Credit Facility covenants at March 31.
- Interest-rate exposure: A hypothetical 1% rate decrease was estimated to reduce annual net investment income by $6.6 million, or $0.10 per share; a 1% increase was estimated to add the same amounts. Actual effects may differ, and the company reported no interest-rate or foreign-currency hedging during the periods.
- Valuation and credit risk: Most investments are Level 3, valued using significant unobservable inputs; actual sale prices may differ materially from reported fair values. The portfolio includes payment-in-kind interest and investments marked below cost. One company remained on non-accrual.
- Control issue and restatement: Management disclosed previously identified material weaknesses involving review of cash and investment reconciliations and review of interest income and non-accrual classifications. Remediation steps were underway; management concluded disclosure controls were effective for this quarter. The comparative 2023 cash-flow statement was restated for a cash and affiliate-liability classification error; the filing says net assets and NAV were unaffected.
- Other events: The company voluntarily delisted its common stock from the Tel Aviv Stock Exchange effective May 8, 2024. The independent accountant’s interim review report was not an audit opinion.
Most important facts for investors to verify
- Confirm the reporting period: this filing is for fiscal Q2 2024, ended March 31, 2024.
- Track NII per share, distributions, and the extent to which distributions remain covered by investment income, especially as interest rates change.
- Review debt maturities, the August 2024 end of the Credit Facility revolving period, asset coverage headroom, and borrowing-base availability after the facility increase.
- Examine portfolio credit quality, non-accrual status, PIK income, unfunded commitments, and subsequent borrower performance.
- Assess Level 3 valuation assumptions and the concentration and performance of major investments, including PSSL.
- Follow remediation of the disclosed material weaknesses and confirm the effects and presentation of the prior-period cash-flow restatement.